Feeding practices and patent ductus arteriosus ligation preferences-are they related?

American Journal of Perinatology

Volumn 27, Issue 8, 2010, Pages 667-673

  Jhaveri, Nami ^a   Soll, Roger F ^b   Clyman, Ronald I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

feeding practices; indomethacin; international; ligation; Patent ductus arteriosus; survey

Indexed keywords

INDOMETACIN;

ARTICLE; ARTIFICIAL VENTILATION; CARDIOVASCULAR SURGERY; FOOD INTAKE; HEALTH CARE PERSONNEL; MEDICAL PRACTICE; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; PROPHYLAXIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIRTH WEIGHT; DUCTUS ARTERIOSUS, PATENT; ENTERAL NUTRITION; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; LIGATION; NEONATOLOGY; QUESTIONNAIRES; RESPIRATION, ARTIFICIAL; UNITED STATES;

EID: 77955548181     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0030-1249764     Document Type: Article

References (29)

1. Fowlie P W., Davis P G. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 2002 (3) CD000174
2. Ment L R., Oh W, Ehrenkranz R A. et al. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics 1994 93 543-550 (Pubitemid 24106595)
3. Schmidt B, Davis P, Moddemann D et al, Trial of Indomethacin Prophylaxis in Preterms Investigators. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001 344 1966-1972
4. Bandstra E S., Montalvo B M., Goldberg R N. et al. Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants. Pediatrics 1988 82 533-542
5. Clyman R I., Chorne N. Patent ductus arteriosus: evidence for and against treatment. J Pediatr 2007 150 216-219
6. Laughon M M., Simmons M A., Bose C L. Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated? Curr Opin Pediatr 2004 16 146-151
7. Bose C L., Laughon M. Treatment to prevent patency of the ductus arteriosus: beneficial or harmful? J Pediatr 2006 148 713-714
8. Kp P, Lanning P, Koivisto M. Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome. Acta Paediatr Scand 1983 72 179-184
9. Cotton R B., Stahlman M T., Bender H W., Graham T P., Catterton W Z., Kovar I. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr 1978 93 647-651
10. Bose C L., Laughon M M. Patent ductus arteriosus: lack of evidence for common treatments. Arch Dis Child Fetal Neonatal Ed 2007 92 F498-F502
11. McCurnin D, Clyman R I. Effects of a patent ductus arteriosus on postprandial mesenteric perfusion in premature baboons. Pediatrics 2008 122 e1262-e1267
12. Cassady G, Crouse D T., Kirklin J W. et al. A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. N Engl J Med 1989 320 1511-1516
13. Dollberg S, Lusky A, Reichman B. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study. J Pediatr Gastroenterol Nutr 2005 40 184-188
14. Sankaran K, Puckett B, Lee D S. et al, Canadian Neonatal Network. Variations in incidence of necrotizing enterocolitis in Canadian neonatal intensive care units. J Pediatr Gastroenterol Nutr 2004 39 366-372
15. Clyman R I., Saha S, Jobe A, Oh W. Indomethacin prophylaxis for preterm infants: the impact of 2 multicentered randomized controlled trials on clinical practice. J Pediatr 2007 150 46-50, e2
16. Chorne N, Leonard C, Piecuch R, Clyman R I. Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatrics 2007 119 1165-1174
17. Madan J C., Kendrick D, Hagadorn J I., Frantz I D. III, National Institute of Child Health and Human Development Neonatal Research Network. Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome. Pediatrics 2009 123 674-681
18. Aranda J V., Clyman R, Cox B et al. A randomized, double-blind, placebo-controlled trial on intravenous ibuprofen L-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants. Am J Perinatol 2009 26 235-245
19. Kobaly K, Schluchter M, Minich N et al. Outcomes of extremely low birth weight (<1 kg) and extremely low gestational age (<28 weeks) infants with bronchopulmonary dysplasia: effects of practice changes in 2000 to 2003. Pediatrics 2008 121 73-81
20. Lemons J A., Bauer C R., Oh W et al, NICHD Neonatal Research Network. Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. Pediatrics 2001 107 E1
21. Kusuda S, Fujimura M, Sakuma I et al, Neonatal Research Network, Japan. Morbidity and mortality of infants with very low birth weight in Japan: center variation. Pediatrics 2006 118 e1130-e1138
22. Patel J, Roberts I, Azzopardi D, Hamilton P, Edwards A D. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. [see comments] Pediatr Res 2000 47 36-42
23. Gournay V, Roze J C., Kuster A et al. Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet 2004 364 1939-1944
24. Vanhaesebrouck S, Zonnenberg I, Vandervoort P, Bruneel E, Van Hoestenberghe M R., Theyskens C. Conservative treatment for patent ductus arteriosus in the preterm. Arch Dis Child Fetal Neonatal Ed 2007 92 F244-F247
25. Vanhaesebrouck P, Allegaert K, Bottu J et al, Extremely Preterm Infants in Belgium Study Group. The EPIBEL study: outcomes to discharge from hospital for extremely preterm infants in Belgium. Pediatrics 2004 114 663-675
26. Costeloe K, Hennessy E, Gibson A T., Marlow N, Wilkinson A R. The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics 2000 106 659-671
27. Brooks J M., Travadi J N., Patole S K., Doherty D A., Simmer K. Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management. Arch Dis Child Fetal Neonatal Ed 2005 90 F235-F239
28. Hans D M., Pylipow M, Long J D., Thureen P J., Georgieff M K. Nutritional practices in the neonatal intensive care unit: analysis of a 2006 neonatal nutrition survey. Pediatrics 2009 123 51-57
29. Jhaveri N, Moon-Grady A, Clyman R I. Early surgical ligation versus a conservative approach for management of patent ductus arteriosus that fail to close after indomethacin treatment. Pediatrics (in press)